Riskpilot← Back to searchSign inGet full accessp.A.c. ApS
APSIn liquidationCVR 41124369Oslo Plads 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 20201 employeeshttps://pokeacell.com/
Revenue 2025
DKK -354K
-51% vs 2024
EBITDA margin
100.0%
+84% vs 2024
Equity ratio
-382.5%
Financial strength
Net profit 2025
DKK -2,5M
+27% vs 2024
| Revenue | DKK -354K | -51% |
| EBITDA | DKK -354K | +84% |
| Net profit | DKK -2,5M | +27% |
| Total assets | DKK 6,4M | -6% |
| Equity | DKK -24,4M | -12% |
| Employees | 1 | — |
Legal name
p.A.c. ApS
CVR number
41124369
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23. januar 2020
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at bedrive forskning, udvikling, licensering og salg af terapeutiske produkter og teknologi til brug inden for naturvidenskabelig forskning, patientbehandling og relaterede forretningsområder.
Address
Oslo Plads 2
Phone
+4553393007
Email
info@pokeacell.com
Website
https://pokeacell.com/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -3.393 | -4.546 | 1.545 | -717 | -354 |
| Staff expenses | -2.373 | -6.028 | -5.229 | -1.296 | -0 |
| EBITDA | -3.062 | -5.394 | -3.821 | -2.169 | -354 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -3.062 | -5.394 | -3.821 | -2.169 | -354 |
| Net financials | -441 | -1.201 | -1.338 | -1.780 | -2.160 |
| Profit before tax | -3.503 | -6.594 | -5.158 | -3.949 | -2.514 |
| Tax | 1.352 | 2.590 | -762 | -446 | 31 |
| Net profit | -4.855 | -9.184 | -4.396 | -3.503 | -2.545 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 15.786 | 10.624 | 7.643 | 6.817 | 6.391 |
| Equity | -4.815 | -13.999 | -18.395 | -21.898 | -24.443 |
| Long-term debt | 20.356 | 23.678 | 24.992 | 26.794 | 29.120 |
| Short-term debt | 245 | 945 | 1.046 | 1.012 | 1.714 |
| Total debt | 20.601 | 24.623 | 26.038 | 27.806 | 30.834 |
EBITDA margin
-35404900.0%
This company
15.8%
Market median
-224081746% vs market
20212025
Equity ratio
-382.5%
This company
38.2%
Market median
-1101% vs market
20212025
Return on equity
-254509400.0%
This company
18.4%
Market median
-1383203361% vs market
20212025
Net profit margin
-254509400.0%
This company
8.1%
Market median
-3142091458% vs market
20212025
Asset turnover
-0.06×
This company
1.12×
Market median
-105% vs market
20212025
Debt / equity
1.26×
This company
0.62×
Market median
-103% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-01-23 – 2021-03-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AR Management | Management | 2020 | — | — |
NL Unofficial title | Unofficial title | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hadrup BioMed Holding ApS | Company | 33.3% | 33.3% | 2020 |
BIOARC HOLDING APS | Company | 33.3% | 33.3% | 2020 |
MOLIOR HOLDING ApS | Company | 33.3% | 33.3% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hadrup BioMed Holding ApS
p.A.c. ApS Board members of p.A.c. ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Reker Cordt | Management | 0 companies |
| Nicholas Lerche-Gredal | Unofficial title | 0 companies |
| Søren Nyboe Jakobsen | Board of Directors | 0 companies |
| Sine Hadrup | Chairman | 0 companies |